brain Logo
DE
  • 61

    We draw inspiration from the biodiversity of nature: from microorganisms, their specific abilities and the enzymes that support these abilities.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2024
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Financial Calendar
      • Investor Events
      • Presentations & Videos
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2025
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • Social Responsibility
    • Environment
    • Corporate Management
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

12.03.2024
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
Corporate Finance
Show Article
07.03.2024
Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying
Technology Products
Show Article
29.02.2024
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
Finance Corporate
Show Article
28.02.2024
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
Finance
Show Article
17.01.2024
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
Corporate Finance
Show Article
20.11.2023
Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy
Technology
Show Article
28.09.2023
BRAIN Biotech AG´s Akribion Genomics team wins first prize in the “BioRiver Boost!” startup competition
Technology
Show Article
14.09.2023
BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
Technology
Show Article
12.09.2023
Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
Technology
Show Article
  • 1
  • 2
  • 3
  • 4
  • 8
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2025 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings